Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: vision loss in my right eye; sudden onset of migraines; extreme fatigue; shortness of breath; muscle weakness; fibromyalgia flare up; balance issues; Dizziness; Elevation in blood sugar; This is a spontaneous report received from a Consumer or other non HCP.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Nov2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 59 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "Diabetes" (unspecified if ongoing); "Fibromyalgia" (ongoing); "unknown autoimmune response" (unspecified if ongoing); "Allergy" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: BNT162b2 (prev dose product=COVID 19,, prev dose brand=Pfizer,, prev dose brand unknown=False,, is bivalent=False,, prev dose lot number=8730ER,, prev dose lot unknown=False,, prev dose administration date=23Mar2021,, prev dose dose number=1,, prev dose vaccine location=Right arm), administration date: 23Mar2021, when the patient was 58-year-old, for COVID-19 Immunization; BNT162b2 (prev dose product=COVID 19,, prev dose brand=Pfizer,, prev dose brand unknown=False,, is bivalent=False,, prev dose lot number=GR8730,, prev dose lot unknown=False,, prev dose administration date=13Apr2021,, prev dose dose number=2,, prev dose vaccine location=Right arm), administration date: 13Apr2021, when the patient was 58-year-old, for COVID-19 Immunization, reaction(s): "Migraine", "vision loss in my right eye", "Extreme Fatigue", "shortness of breath", "elevation in blood sugar", "dizziness", "Muscle weakness", "Fibromyalgia flare up", "Balance issues". The following information was reported: DIZZINESS (disability) with onset 2021, outcome "recovering"; BLOOD GLUCOSE INCREASED (disability) with onset 2021, outcome "recovering", described as "Elevation in blood sugar"; BALANCE DISORDER (disability) with onset 2021, outcome "recovering", described as "balance issues"; FATIGUE (disability) with onset 2021, outcome "recovering", described as "extreme fatigue"; FIBROMYALGIA (disability) with onset 2021, outcome "recovering", described as "fibromyalgia flare up"; MUSCULAR WEAKNESS (disability) with onset 2021, outcome "recovering", described as "muscle weakness"; DYSPNOEA (disability) with onset 2021, outcome "recovering", described as "shortness of breath"; MIGRAINE (disability) with onset 2021, outcome "recovering", described as "sudden onset of migraines"; BLINDNESS UNILATERAL (disability, medically significant) with onset 2021, outcome "recovering", described as "vision loss in my right eye". The patient underwent the following laboratory tests and procedures: Blood glucose: (2021) increased/elevation; SARS-CoV-2 test: (2021) Negative. Therapeutic measures were taken as a result of blindness unilateral, migraine, fatigue, dyspnoea, muscular weakness, fibromyalgia, balance disorder, dizziness, blood glucose increased.  Clinical course: It was unknown if other vaccine was taken in four weeks. Other medications in two weeks included likely some "blood pressure medication". She had a sudden onset of migraines, vision loss in right eye, extreme fatigue, shortness of breath, elevation in blood sugar requiring medication, dizziness, muscle weakness, fibromyalgia flare up and balance issues. Adverse event resulted in doctor or other healthcare professional office clinic visit. Outcome reported as recovering and adverse event treatment included medications, PT, etc. No covid prior vaccination and tested for covid post vaccination for which nasal swab, covid test result showed negative.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202400059694 same patient/AE/drug, different dose;